Mark Emalfarb
Founder chez DYADIC INTERNATIONAL, INC.
Fortune : 8 M $ au 31/03/2024
Profil
Mark A.
Emalfarb is the founder of Dyadic International, Inc., which was founded in 1979.
He currently holds the position of President, Chief Executive Officer & Director at Dyadic International, Inc. He is also the Chairman & Chief Executive Officer at Dyadic International (USA), Inc. and the Director at Biotechnology Development for Industry in Pharmaceuticals SLU.
Mr. Emalfarb completed his undergraduate degree at the University of Iowa in 1977.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DYADIC INTERNATIONAL, INC.
16,16% | 13/03/2024 | 4 656 947 ( 16,16% ) | 8 M $ | 31/03/2024 |
Postes actifs de Mark Emalfarb
| Sociétés | Poste | Début |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Founder | 01/01/1979 |
Dyadic International (USA), Inc.
 Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Chief Executive Officer | 05/10/2011 |
Biotechnology Development for Industry in Pharmaceuticals SLU
 Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Director/Board Member | 13/09/2017 |
Formation de Mark Emalfarb
| University of Iowa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DYADIC INTERNATIONAL, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |
